Benchmark Reiterates “Buy” Rating for Valaris (NYSE:VAL)
Benchmark restated their buy rating on shares of Valaris (NYSE:VAL – Free Report) in a report published on Tuesday, Benzinga reports. The firm currently has...
LiveRamp (NYSE:RAMP) Given “Buy” Rating at Benchmark
Benchmark restated their buy rating on shares of LiveRamp (NYSE:RAMP – Free Report) in a research report report published on Tuesday morning, Benzinga reports. They...
OLO (NYSE:OLO) Given New $9.00 Price Target at Royal Bank of Canada
OLO (NYSE:OLO – Free Report) had its target price trimmed by Royal Bank of Canada from $11.00 to $9.00 in a research report report published...
National Bankshares Boosts Trisura Group (TSE:TSU) Price Target to C$62.00
Trisura Group (TSE:TSU – Free Report) had its target price boosted by National Bankshares from C$60.00 to C$62.00 in a report published on Tuesday morning,...
Mirati Therapeutics (NASDAQ:MRTX) Downgraded by Leerink Partnrs
Leerink Partnrs downgraded shares of Mirati Therapeutics (NASDAQ:MRTX – Free Report) from an outperform rating to a market perform rating in a research report sent...
RS Group plc (LON:RS1) Insider Purchases £145,575 in Stock
RS Group plc (LON:RS1 – Get Free Report) insider Simon Pryce bought 22,500 shares of the stock in a transaction on Tuesday, November 7th. The...